Raymond James on Profound Medical Corp. (PROF): 6-month data strong, even more robust 12-month data expected

March 16, 2026 3:44 PM EDT Send to a Friend
Raymond James analyst Michael Freeman reiterated an Outperform rating and $11.00 price target on Profound Medical Corp. (NASDAQ: PROF)The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login